In a recent post she authored for Brookings Institution’s Health360 blog, Elisabeth Wynne, a clinician and visiting scholar at the Center for Health Policy, wrote that postmarket data “will allow us to evaluate important questions such as the quality of the device, short and long term outcomes, comparative effectiveness across devices of the same type, and how the devices work in subpopulations such as age, gender, or race.”